FDA Warns of Increased Risk of Suicidal Thoughts from Drugs Used to Treat Epilepsy, Migraines and Bipolar Disorder
At the end of January, the FDA issued a press release warning health care professionals about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take...
Read more